International Conference on Genetic Biomarkers and Diagnostic Techniques
(ICGBDT-26)

7th November 2026 || Hyderabad - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Genetic Biomarkers and Diagnostic Techniques (ICGBDT), scheduled to be held on 7th November 2026 in Hyderabad, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Genetics.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Genetic Biomarkers
    This track will explore the latest discoveries in genetic biomarkers and their implications for disease diagnosis and treatment. Emphasis will be placed on innovative approaches to biomarker identification and validation. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Molecular Diagnostics: Techniques and Applications
    This session will focus on cutting-edge molecular diagnostic techniques and their applications in clinical settings. Participants will discuss the integration of these techniques into routine diagnostics and their impact on patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Genomic Assays in Clinical Genomics
    This track will cover the development and application of genomic assays in clinical genomics. Discussions will include the challenges and opportunities presented by these assays in the context of personalized medicine. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Biomarker Discovery and Validation
    This session will address the methodologies and technologies used in biomarker discovery and validation. Emphasis will be placed on the importance of robust validation processes to ensure clinical applicability. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Predictive and Prognostic Markers in Disease Management
    This track will examine the role of predictive and prognostic markers in the management of various diseases. Participants will discuss how these markers can inform treatment decisions and improve patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – High-Throughput Screening in Biomarker Research
    This session will highlight the use of high-throughput screening technologies in the identification of novel biomarkers. The focus will be on innovative applications and the potential for accelerating biomarker discovery. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 07 – Liquid Biopsy: A Paradigm Shift in Diagnostics
    This track will explore the emerging field of liquid biopsy and its implications for non-invasive diagnostics. Discussions will include the technical challenges and clinical applications of liquid biopsy in various diseases. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 08 – Mutation Detection Techniques in Genomics
    This session will focus on the latest techniques for mutation detection in genomic studies. Participants will discuss the significance of these techniques in understanding disease mechanisms and treatment responses. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 09 – Gene Panels and Their Clinical Utility
    This track will examine the development and application of gene panels in clinical practice. Emphasis will be placed on their role in personalized medicine and the challenges associated with their implementation. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Protein Biomarkers: Discovery and Applications
    This session will focus on the discovery and application of protein biomarkers in disease diagnosis and monitoring. Participants will discuss the technological advancements that facilitate protein biomarker research. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 11 – Therapeutic Biomarkers and Targeted Therapies
    This track will explore the role of therapeutic biomarkers in the development of targeted therapies. Discussions will include the implications of these biomarkers for treatment efficacy and patient stratification. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228